Used For

This assay measures serum IgM antibodies recognizing polysaccharide antigens from the four Neisseria meningococcal vaccine. The meningococcal vaccine response is best evaluated by testing pre-vaccination

and post-vaccination samples in parallel. A two fold or greater increase for at least two serogroups is expected

when comparing post-vaccination to pre-vaccination results. N .meningtidis IgG levels peak approximately one month post-vaccination, but decline markedly by two years.